L. Intorre et al., ENROFLOXACIN THEOPHYLLINE INTERACTION - INFLUENCE OF ENROFLOXACIN ON THEOPHYLLINE STEADY-STATE PHARMACOKINETICS IN THE BEAGLE DOG, Journal of veterinary pharmacology and therapeutics, 18(5), 1995, pp. 352-356
Enrofloxacin, a quinolone antibiotic developed exclusively for use in
animals, was investigated for its effects on the steady-state pharmaco
kinetics of theophylline in six healthy Beagle dogs. A sustained-relea
se theophylline formulation was given alone (20 mg/kg per os twice dai
ly at 12 h intervals) for 9 days and then co-administered with enroflo
xacin (5 mg/kg i.v, once a day) for 5 days. Mean trough theophylline c
oncentrations progressively and significantly increased during the fiv
e days of enrofloxacin co-administration. Theophylline clearance and c
oncentration-time profile were significantly changed by enrofloxacin c
o-administration. No significant change was observed in enrofloxacin p
harmacokinetics, The kinetic interaction between theophylline and enro
floxacin could be of clinical significance and may require plasma drug
concentration monitoring and adjustment of theophylline dosage.